Today's hearing provides us with an opportunity to examine perhaps one of the most important aspects of the 21st Century Cures Initiative: what does medical innovation or faster cures mean for patients. Keeping our work centered on the patient and understanding the patient perspective will bring much needed focus on results for patients who may lack adequate treatment options. Remember, there are only effective treatments for 500 of the 7,000 known diseases impacting patients today.
One of our witnesses today,
I want to welcome our witnesses today and look forward to learning more about the assessment of benefits and risks central to medical product development, regulations, and healthcare decision-making, and the tradeoffs between desired benefits and tolerable risks.
Read this original document at: http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Health/20140711/HHRG-113-IF14-MState-P000373-20140711.pdf
Most Popular Stories
- Prosecutor to Investigate Walmart Police Shooting
- GM to Announce New Jobs in Tennessee
- Mark Sanchez Suddenly a Hot QB Commodity
- Smith & Wesson Misses Target
- Emirates Hit Libyan Targets With Airstrikes
- Marco Rubio Warns Obama on Deportations
- Michael Brown Funeral: Can Americans Change the Script of Violence?
- American Killed With ISIS Fighters in Syria
- Surf's Up! SoCal Prepares for Big Storm Surf
- Ford Hires 300 at Louisville Lincoln Plant